To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo ...

Although alterations in several specific genes have been implicated in breast cancer progression, greater understanding of the molecular basis of the disease may result from the evaluation of global ...

The Global MiRNA Microarray Kits And Reagents Market is projected to grow at a CAGR of 8.5% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that ...

Poly(N-isopropylacrylamide) (PNIPAM) hydrogel undergoes significant but precise changes in size between 20 and 40 °C, making ...

New studies reveal that optical genome mapping (OGM) can detect chromosomal abnormalities linked to recurrent pregnancy loss, offering hope to affected families.

The availability in computerized form of the published literature on genes is a potentially rich source of information for the interpretation of microarray data. Automated text processing confronts ...

The researchers reported that hundreds of genes involved in blood-pressure regulation, inflammatory signaling, lipid handling ...

The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.

Suraksha Clinic and Diagnostics expands its presence in Kolkata with new diagnostics centre: Our Bureau, Mumbai Tuesday, November 25, 2025, 15:30 Hrs [IST] Suraksha Diagnostic Lim ...

The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01 billion in 2025 and is projected to advance at a resilient ...

Researchers at Dartmouth–Hitchcock Medical Center investigated whether OGM could detect harmful chromosomal changes in patients with a family history or risk of recurrent pregnancy loss who had ...

Following publication of KEYNOTE-689 Phase 3 results confirming the role of perioperative checkpoint inhibition in head and neck cancer, GeoVax announced plans for a Phase 2 trial (AdPNP-203) ...